Total Funding
71
42
Total FundingGrant raised
Growth Score 71 in past quarter
-5 pts
Heat Score 42 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
148181
Noble is a producer of silver-based advanced material technologies designed for mission-critical applications.
Christopher M. Cashman: DirectorPast Role: Marinus Pharmaceuticals, Executive Chairman
Jeff Keane: Chief Executive Officer
About the Company
Noble Biomaterials is a global leader in antimicrobial and conductivity solutions for soft surface applications. They supply medical components to the US military, and a US EPA–registered antimicrobial manufacturer.
